Xiaoming Xie

3.0k total citations · 2 hit papers
46 papers, 1.9k citations indexed

About

Xiaoming Xie is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiaoming Xie has authored 46 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 21 papers in Cancer Research and 18 papers in Oncology. Recurrent topics in Xiaoming Xie's work include Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (7 papers) and Breast Cancer Treatment Studies (7 papers). Xiaoming Xie is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (7 papers) and Breast Cancer Treatment Studies (7 papers). Xiaoming Xie collaborates with scholars based in China, United States and Spain. Xiaoming Xie's co-authors include Hailin Tang, Yutian Zou, Xinhua Xie, Xiangsheng Xiao, Anli Yang, Shaoquan Zheng, Dingbo Shi, Jingshu Wang, Xinpei Deng and Cheng Qian and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Xiaoming Xie

46 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A novel axis of circKIF4A-miR-637-STAT3 promotes brain metastasis in triple-negative breast cancer

2023 137 citations Song Wu, Hongbo Zhu et al. Cancer Letters profile →
Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer

2024 106 citations Xueqi Ou, Jindong Xie et al. Drug Resistance Updates profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaoming Xie China	27	1.2k	827	517	258	246	46	1.9k
Meng‐Chi Yen Taiwan	27	1.1k 0.9×	590 0.7×	466 0.9×	319 1.2×	417 1.7×	81	2.0k
Ling‐Wen Ding Singapore	29	1.6k 1.4×	541 0.7×	506 1.0×	318 1.2×	260 1.1×	65	2.4k
Pei Zhang China	23	1.2k 1.0×	636 0.8×	356 0.7×	375 1.5×	368 1.5×	109	2.1k
Xi Jin China	26	1.3k 1.1×	1.0k 1.2×	775 1.5×	668 2.6×	326 1.3×	83	2.5k
Carman A. Giacomantonio Canada	23	1.1k 0.9×	591 0.7×	935 1.8×	225 0.9×	227 0.9×	46	2.2k
Chaoliu Dai China	17	870 0.7×	453 0.5×	627 1.2×	248 1.0×	363 1.5×	44	1.8k
Yirong Li China	23	953 0.8×	527 0.6×	345 0.7×	241 0.9×	232 0.9×	49	1.6k

Countries citing papers authored by Xiaoming Xie

Since Specialization

Citations

This map shows the geographic impact of Xiaoming Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoming Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoming Xie more than expected).

Fields of papers citing papers by Xiaoming Xie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoming Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoming Xie. The network helps show where Xiaoming Xie may publish in the future.

Co-authorship network of co-authors of Xiaoming Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoming Xie. A scholar is included among the top collaborators of Xiaoming Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoming Xie. Xiaoming Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Jinhui, Song Wu, Jindong Xie, et al.. (2025). PRMT1-Mediated PARP1 Methylation Drives Lung Metastasis and Chemoresistance via P65 Activation in Triple-Negative Breast Cancer. Research. 8. 854–854. 2 indexed citations

Xie, Jindong, Xinpei Deng, Yi Xie, et al.. (2024). Multi‐omics analysis of disulfidptosis regulators and therapeutic potential reveals glycogen synthase 1 as a disulfidptosis triggering target for triple‐negative breast cancer. SHILAP Revista de lepidopterología. 5(3). e502–e502. 44 indexed citations

Zou, Yutian, Anli Yang, Bo Chen, et al.. (2024). crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer. Drug Resistance Updates. 77. 101126–101126. 42 indexed citations

Wu, Song, Hongbo Zhu, Feiyue Wu, et al.. (2023). A novel axis of circKIF4A-miR-637-STAT3 promotes brain metastasis in triple-negative breast cancer. Cancer Letters. 581. 216508–216508. 137 indexed citations breakdown →

Tian, W. H., Yuhui Tang, Jindong Xie, et al.. (2023). AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer. Cell Death and Disease. 14(12). 790–790. 17 indexed citations

Yang, Lu, Ning Li, Jian Li, et al.. (2020). Synergistic therapeutic effect of combined PDGFR and SGK1 inhibition in metastasis-initiating cells of breast cancer. Cell Death and Differentiation. 27(7). 2066–2080. 31 indexed citations

Yu, Ping, Peng Liu, Yutian Zou, et al.. (2020). Breast‐conserving therapy shows better prognosis in mucinous breast carcinoma compared with mastectomy: A SEER population‐based study. Cancer Medicine. 9(15). 5381–5391. 8 indexed citations

Xiao, Weikai, Shaoquan Zheng, Xinhua Xie, et al.. (2020). SOX2 Promotes Brain Metastasis of Breast Cancer by Upregulating the Expression of FSCN1 and HBEGF. Molecular Therapy — Oncolytics. 17. 118–129. 34 indexed citations

Zou, Yutian, Jie‐Ying Liang, Weikai Xiao, et al.. (2020). Identification and validation of a combined hypoxia and immune index for triple‐negative breast cancer. Molecular Oncology. 14(11). 2814–2833. 65 indexed citations

10.

Zou, Yutian, Xiaoqian Hu, Shaoquan Zheng, et al.. (2020). Discordance of immunotherapy response predictive biomarkers between primary lesions and paired metastases in tumours: A systematic review and meta-analysis. EBioMedicine. 63. 103137–103137. 57 indexed citations

11.

Tang, Hailin, Cailu Song, Feng Ye, et al.. (2019). miR‐200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer. Journal of Cellular and Molecular Medicine. 23(12). 8114–8127. 32 indexed citations

12.

Zou, Yutian, Shaoquan Zheng, Xinpei Deng, et al.. (2019). The Role of Circular RNA CDR1as/ciRS-7 in Regulating Tumor Microenvironment: A Pan-Cancer Analysis. Biomolecules. 9(9). 429–429. 100 indexed citations

13.

Xiao, Weikai, Yutian Zou, Shaoquan Zheng, et al.. (2018). Primary tumor resection in stage IV breast cancer: A systematic review and meta-analysis. European Journal of Surgical Oncology. 44(10). 1504–1512. 36 indexed citations

14.

Luo, Liyun, Hailin Tang, Ling Li, et al.. (2018). LINC01638 lncRNA activates MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation in triple-negative breast cancer. Oncogene. 37(47). 6166–6179. 104 indexed citations

15.

Ye, Feng, Mei Li, Ping Yu, et al.. (2017). Application of a novel prognostic invasive lesion index in ductal carcinoma in situ with minimal invasion of the breast. Cancer Medicine. 6(11). 2489–2496. 1 indexed citations

16.

Liu, Yang, Jian Zhang, Rong Huang, et al.. (2017). Influence of occupation and education level on breast cancer stage at diagnosis, and treatment options in China. Medicine. 96(15). e6641–e6641. 45 indexed citations

17.

Yu, Daojiang, et al.. (2012). [Application of slender narrow pedicle flap in facial skin cancer treatment].. PubMed. 28(3). 181–4. 2 indexed citations

18.

Xiao, Xiangsheng, Dingbo Shi, Liqun Liu, et al.. (2011). Quercetin Suppresses Cyclooxygenase-2 Expression and Angiogenesis through Inactivation of P300 Signaling. PLoS ONE. 6(8). e22934–e22934. 209 indexed citations

19.

Wu, Hao, C. Webber, Karen Beattie, et al.. (2007). Prevalence of knee abnormalities in patients with osteoarthritis and anterior cruciate ligament injury identified with peripheral magnetic resonance imaging: a pilot study.. PubMed. 58(3). 167–75. 13 indexed citations

20.

Droździk, Marek, Cheng Qian, Xiaoming Xie, et al.. (2000). Combined gene therapy with suicide gene and interleukin-12 is more efficient than therapy with one gene alone in a murine model of hepatocellular carcinoma. Journal of Hepatology. 32(2). 279–286. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meng‐Chi Yen Breakdown of academic impact, for papers by Ling‐Wen Ding Breakdown of academic impact, for papers by Pei Zhang Breakdown of academic impact, for papers by Xi Jin Breakdown of academic impact, for papers by Carman A. Giacomantonio Breakdown of academic impact, for papers by Chaoliu Dai Breakdown of academic impact, for papers by Yirong Li